Company Profiles

driven by the PitchBook Platform

Atacama Labs

Description

Developer of drugs intended to offer oral solid dosage for patients. The company's drugs are made by using technologies and galenic forms from existing excipients or nutraceuticals to enhance product performance and extend the product life-cycle, enabling patients to avail fast dissolving, controlled release and enhanced capsules.

2004

Founded

OOB

Status

1-10

Employees

Out of Business

Latest Deal Type

$3.28M

Total Amount Raised

Description

Developer of drugs intended to offer oral solid dosage for patients. The company's drugs are made by using technologies and galenic forms from existing excipients or nutraceuticals to enhance product performance and extend the product life-cycle, enabling patients to avail fast dissolving, controlled release and enhanced capsules.

Website:

www.atacamalabs.com

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Drug Delivery

Primary Office

Fredrikinkatu 61 6th floor 00100 HelsinkiFinland +358 (0)92 510 7147
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Atacama Labs's full profile, request a free trial.

    Atacama Labs Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Atacama Labs Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Robert Lammens Ph.DChief Technology Officer
    Robert Lammens Ph.D Chief Technology Officer

    Atacama Labs Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Ari-Pekka HameriSelfBoard Member000 0000
    Gregoire NotzSelfBoard Member000 0000
    Jari OvaskainenSelfChairman000 0000
    Ari-Pekka Hameri Board Member Self
    Gregoire Notz Board Member Self
    Jari Ovaskainen Chairman Self
    Request full access to PitchBook